ACCC logo
Facebook  LinkedIn  Twitter  ACCC Youtube Channel  ACCCBuzz blog

Association of Community Cancer Centers

The leading education and advocacy organization for the multidisciplinary cancer team

ACCCBuzz Blog  Find a Cancer Program  Log in to MyNetwork

Home > Mediaroom > Press Releases > 2010 > David S. Alberts, MD, to be Honored at ACCC's National Oncology Economics Conference

FOR INFORMATION CONTACT:
Lori Gardner, Senior Director
Communications & Marketing
301.984.9496 ext. 226
lgardner@accc-cancer.org

ACCC News Release

For Immediate Release: September 24, 2010

David S. Alberts, MD, to be Honored at ACCC's National Oncology Economics Conference

Rockville, Md.—David S. Alberts, MD, will receive the Association of Community Cancer Centers’ 2010 Clinical Research Award at ACCC’s 27th National Oncology Economics Conference, to be held September 29 – October 2, 2010, in St. Louis, Mo. He will be honored on September 30 for his extensive research, leadership, and commitment to individuals with cancer. Dr. Alberts is Regents Professor of Medicine, Pharmacology, Nutritional Science, and Public Health at the University of Arizona College of Medicine, and Director of the Arizona Cancer Center.

Dr. Alberts has had a strong career focus on translational cancer prevention and treatment research. The emphasis of his laboratory-based and clinical research has been on the chemoprevention and treatment of cancers of the breast, colon, ovary, and skin. Clinically, Dr. Alberts pioneered new treatments for advanced ovarian cancers, including in vitro tumor cell chemosensitivity testing for personalized medicine strategies, intraperitoneal chemotherapy, and maintenance chemotherapy.

Presently, Dr. Alberts helps to coordinate phase I and II and pharmacokinetic drug studies at the Arizona Cancer Center for molecularly targeted chemopreventive agents and anticancer drugs. His laboratory research is concentrated on the evaluation of new surrogate endpoint biomarkers for cancer prevention trials with a special focus on precursor lesions for bladder, breast, colon, cervical, endometrial, ovarian, prostate, and skin cancers, using quantitative histopathology (i.e, karyometric) approaches.

During his career, Dr. Alberts has served as an advisor to numerous cancer research foundations and committees, including chair of the Oncologic Drug Advisory Committee to the U.S. Food and Drug Administration (1984-1986). He was a member of the National Cancer Institute’s Board of Counselors (to the Division of Cancer Prevention, 1990-1994), the Board of Scientific Advisors (1999-2006), and was on the coordinating subcommittee to the Clinical Translational Advisory Committee, NCI (2006-2009). In June 2001, he was acknowledged by Science to be one of the top three National Institutes of Health-funded clinical researchers in the United States. In 2003 the American Association for Cancer Research (AACR) recognized his contributions to clinical care in the field of cancer with the Joseph H. Burchenal Clinical Research Award, and in 2004 the American Society for Preventive Oncology gave him its Distinguished Career Award for research excellence. Also in 2004, the AACR awarded Dr. Alberts with its AACR-Cancer Research and Prevention Foundation Award for Excellence in Cancer Prevention Research Worldwide.

Dr. Alberts has authored or co-authored more than 500 peer-reviewed publications, more than 100 book chapters and 60 invited articles, and has served as editor and co-editor of six books (e.g., "Fundamentals of Cancer Prevention," Second Edition, Springer Verlag, 2009, and Intraperitoneal Therapy for Ovarian Cancer, Springer Verlag, 2010). He has served on the editorial boards of several peer-reviewed scientific journals, including as associate editor for Cancer Research from 1989-2002. Between 2002 and 2008, he acted as the co-editor-in-chief of Cancer Epidemiology, Biomarkers & Prevention, the leading cancer public health research journal worldwide.

Dr. Alberts received his medical degree from University of Virginia School of Medicine. He conducted his internship at the University of Wisconsin, before becoming a clinical associate in medical oncology at NCI’s Baltimore Cancer Research Center. Dr. Alberts conducted his internal medicine residency at the University of Minnesota and then served on the faculty of the University of California, San Francisco, for five years and obtained board certification in medicine and medical oncology.

Among the past winners of ACCC’s prestigious annual Outstanding Achievement in Clinical Research Award are Charles M. Balch, MD, FACS; David H. Johnson, MD; Lillian M. Nail, PhD, RN, FAAN; Daniel D. Von Hoff, MD, FACP; Saul Rivkin, MD; Henry Lynch, MD; and Vincent DeVita, Jr, MD.

About the Association of Community Cancer Centers
The Association of Community Cancer Centers (ACCC) is the leading advocacy and education organization for the multidisciplinary cancer care team. More than 23,000 cancer care professionals from over 2,500 hospitals and practices nationwide are affiliated with ACCC. Providing a national forum for addressing issues that affect community cancer programs, ACCC is recognized as the premier provider of resources for the entire oncology care team. Our members include medical and radiation oncologists, surgeons, cancer program administrators and medical directors, senior hospital executives, practice managers, pharmacists, oncology nurses, radiation therapists, social workers, and cancer program data managers. For more information, visit ACCC's website at www.accc-cancer.org. Follow us on Facebook, Twitter, LinkedIn, and read our blog, ACCCBuzz.

Copyright © 2017 Association of Community Cancer Centers. All Rights Reserved.
1801 Research Boulevard, Suite 400, Rockville, MD 20850  |  Tel.: 301.984.9496  |  Fax: 301.770.1949

CONTACT US